Correlation Between Maximal Tongue Pressure and Swallowing Function in Spinal and Bulbar Muscular Atrophy

被引:5
|
作者
Gwak, Dae-Won [1 ]
Jung, Seung-Hwan [1 ]
Min, Yu-Sun [1 ]
Park, Jin-Sung [2 ]
Cho, Hee-Jin [2 ]
Park, Donghwi [3 ]
Hong, Min Woo [4 ]
Kang, Min-Gu [4 ]
机构
[1] Kyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Rehabil Med, Daegu, South Korea
[2] Kyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Neurol, Daegu, South Korea
[3] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Phys Med & Rehabil, Ulsan, South Korea
[4] Dong A Univ, Dong A Univ Hosp, Coll Med, Dept Phys Med & Rehabil, Busan, South Korea
来源
FRONTIERS IN NEUROLOGY | 2021年 / 12卷
关键词
bulbo-spinal atrophy X-linked; motor neuron disease; neurodegenerative diseases; tongue; deglutition disorders; RECESSIVE BULBOSPINAL NEURONOPATHY; KENNEDY-DISEASE; DYSPHAGIA; DIAGNOSIS;
D O I
10.3389/fneur.2021.704788
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Spinal and bulbar muscular atrophy (SBMA) is an X-lined motor neuron disease characterized by progressive muscle weakness, bulbar palsy, and dysphagia. Dysphagia is associated with tongue weakness, which is a common manifestation of SBMA. This study aimed to investigate the correlations between tongue pressure and dysphagia in patients with SBMA. Materials and Methods: Thirty-nine genetically confirmed SBMA patients underwent a videofluoroscopic swallowing study (VFSS) and tongue pressure assessment. Then, we analyzed the maximal tongue pressure (MTP), oral transit time, penetration-aspiration scale (PAS), videofluoroscopic dysphagia scale (VDS), amyotrophic lateral sclerosis functional rating scale-revised (ALSFRS-R), and 6-min walk test (6MWT). Pearson and Spearman correlation coefficients were calculated to analyze the association of the MTP with clinical, swallowing, and functional parameters. Results: In the correlation analysis, MTP was negatively correlated with disease duration (r = -0.396, p = 0.013) and VDS (r = -0.426, p = 0.007), and positively correlated with ALSFRS-R (r = 0.483, p = 0.002) and 6MWT (r = 0.396, p = 0.013). The bulbar (r = 0.367, p = 0.022) and gross motor (r = 0.486, p = 0.002) domains of the ALSFRS-R were correlated with MTP. Conclusion: Tongue pressure assessment can be used as a safe and easy tool to assess swallowing function in SBMA patients. Moreover, MTP reflects functional states, including activities of daily living and gait performance, showing it to be a potential biomarker for physical performance in SBMA.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Molecular diagnosis of spinal and bulbar muscular atrophy in Slovakia
    Zelinkova, H.
    Kolejakova, Lexova K.
    Spalek, P.
    Chandoga, J.
    Konkolova, J.
    Bohmer, D.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2016, 117 (03): : 137 - 141
  • [22] Phase 2 Trial of Leuprorelin in Patients with Spinal and Bulbar Muscular Atrophy
    Banno, Haruhiko
    Katsuno, Masahisa
    Suzuki, Keisuke
    Takeuchi, Yu
    Kawashima, Motoshi
    Suga, Noriaki
    Takamori, Motoko
    Ito, Mizuki
    Nakamura, Tomohiko
    Matsuo, Koji
    Yamada, Shinichi
    Oki, Yumiko
    Adachi, Hiroaki
    Minamiyama, Makoto
    Waza, Masahiro
    Atsuta, Naoki
    Watanabe, Hirohisa
    Fujimoto, Yasushi
    Nakashima, Tsutomu
    Tanaka, Fumiaki
    Doyu, Manabu
    Sobue, Gen
    ANNALS OF NEUROLOGY, 2009, 65 (02) : 140 - 150
  • [23] Androgen-dependent impairment of myogenesis in spinal and bulbar muscular atrophy
    Malena, Adriana
    Pennuto, Maria
    Tezze, Caterina
    Querin, Giorgia
    D'Ascenzo, Carla
    Silani, Vincenzo
    Cenacchi, Giovanna
    Scaramozza, Annarita
    Romito, Silvia
    Morandi, Lucia
    Pegoraro, Elena
    Russell, Aaron P.
    Soraru, Gianni
    Vergani, Lodovica
    ACTA NEUROPATHOLOGICA, 2013, 126 (01) : 109 - 121
  • [24] Disentangling balance impairments in spinal and bulbar muscular atrophy
    Anagnostou, E.
    Zachou, A.
    Breza, M.
    Kladi, A.
    Karadima, G.
    Koutsis, G.
    NEUROSCIENCE LETTERS, 2019, 705 : 94 - 98
  • [25] Neuropathology and Therapeutic Intervention in Spinal and Bulbar Muscular Atrophy
    Banno, Haruhiko
    Katsuno, Masahisa
    Suzuki, Keisuke
    Tanaka, Fumiaki
    Sobue, Gen
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2009, 10 (03) : 1000 - 1012
  • [26] Pathogenesis-targeting therapeutics for spinal and bulbar muscular atrophy (SBMA)
    Suzuki, Keisuke
    Kastuno, Masahisa
    Banno, Haruhiko
    Sobue, Gen
    NEUROPATHOLOGY, 2009, 29 (04) : 509 - 516
  • [27] Disease mechanism, biomarker and therapeutics for spinal and bulbar muscular atrophy (SBMA)
    Hashizume, Atsushi
    Fischbeck, Kenneth H.
    Pennuto, Maria
    Fratta, Pietro
    Katsuno, Masahisa
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2020, 91 (10) : 1085 - 1091
  • [28] PATIENT-IDENTIFIED IMPACT OF SYMPTOMS IN SPINAL AND BULBAR MUSCULAR ATROPHY
    Guber, Robert D.
    Kokkinis, Angela D.
    Schindler, Alice B.
    Bendixen, Roxanna M.
    Heatwole, Chad R.
    Fischbeck, Kenneth H.
    Grunseich, Christopher
    MUSCLE & NERVE, 2018, 57 (01) : 40 - 44
  • [29] Therapeutic targeting of the polyglutamine androgen receptor in Spinal and Bulbar Muscular Atrophy
    Sangotra, Agamjot
    Lieberman, Andrew P.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2025, 29 (1-2) : 29 - 41
  • [30] Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy (SBMA)
    Banno, Haruhiko
    Katsuno, Masahisa
    Suzuki, Keisuke
    Tanaka, Fumiaki
    Sobue, Gen
    CELL AND TISSUE RESEARCH, 2012, 349 (01) : 313 - 320